Preclinical Toxicology: Building a Strong Foundation for Drug Development

Why Preclinical Toxicology Is a Critical Step in Drug Development The journey from drug discovery to clinical development depends heavily on the quality of preclinical safety data. A poorly designed toxicology study can lead to delays, additional studies, increased development costs, and challenges during regulatory submissions. Preclinical toxicology is therefore much more than a regulatory […]

Preclinical Microbiology: Advancing Drug Development and Safety Testing

Microbiology is a cornerstone of drug discovery, playing a pivotal role in ensuring the safety, efficacy, and quality of pharmaceutical products. Among its many applications, preclinical microbiology is crucial for advancing drug development and safety testing. By addressing microbiological factors early in the drug discovery cycle, pharmaceutical companies can prevent costly errors and meet regulatory […]

From Target Identification to Approval: Understanding Drug Discovery Cycles

Introduction to Drug Discovery Cycles The drug discovery process is an intricate and multi-phase journey that transforms a scientific concept into an approved therapeutic solution. Starting with target identification and culminating in regulatory approval, each phase plays a vital role in ensuring that new drugs are safe and effective for patients. Understanding these stages is […]

The Role of LASA in Building a Sustainable Preclinical Economy in India

Building a Sustainable Preclinical Research Landscape in India India’s preclinical research landscape has made tremendous strides in recent years, thanks to the combined efforts of academic institutions, the pharmaceutical industry, government agencies, and professional organizations. With its vast diversity in biological and environmental factors, India is uniquely positioned to lead in preclinical studies, particularly in […]